The activities of the Section include organization of meetings, workshops, round tables, brain-storming sessions and any other activities to ensure that expertise in the field of Applied Genome Research is optimized and available to support all facets of Biotechnology in Europe (Health, Agro-food, Environment, Chemicals).

Events

20-23 August 2004, University of Aarhus, Denmark
Workshop on Applied Functional Genomics
Supported by the EFB Section on Applied Functional Genomics and the European Science Foundation Programme on Integrated Approaches for Functional Genomics.
Session Topics will include High Throughput Technologies, Bioinformatics, Protein Profiling/Proteomics, Epigenetics, the RNA World Ageing and Age-releated Diseases.

For further information about the Section on Applied Functional Genomics, please contact the Section Chairman:

Prof. Dr. Marco R. Soria (chairman)
Department of Experimental & Clinical Medicine 'G. Salvatore'
Magna Graecia University School of Medicine
Via T. Campanella, 115
I-88100 Catanzaro
Phone +39 - 0961 77 08 80
Fax +39 - 0961 77 74 35
email: soria@unicz.it

Made by Genetic Engineering

• A lipase for detergents and a vaccine against Hepatitis B (1991)
• Human insulin and human growth hormone (1992)
• Interferon-alfa and Protein G (1992)
• AIDS diagnostics by use of recombinant antigens and a new desizing shows the changing nature of enzyme production (1995)
• Erythropoietin and Interferon beta-1b (1995)
• Interferon gamma and rabies vaccine (1996) (600k)
• Tissue plasminogen activator and Granulocyte-macrophage colony-stimulating factor (1998)
• Coagulation factor VII and Folicle stimulating hormone (1998)
• Alzheimer tau test and Detergent cellulase (1998)
• Chymosin and Phytase (1999)
• Glucocerebrosidase and Lyme disease vaccine (2000)
• Glucagon and LH (2000)

2. DIDERICHSEN B, FRYKLUND L and PÜHLER A
How Baker's yeast became a source of Insulin
Genotropin - A fascinating story of successful biomedical progress
Biotech Forum Europe 1992; 9 : 144-5

3. RYSER S, HJORTH R and PÜHLER A, DIDERICHSEN B
Interferon-alfa - Progress in cancer therapy
Recombinant Protein G for purification of monoclonal antibodies
Biotech Forum Europe 1992; 9 : 641-2

4. BAUMANN E and DIDERICHSEN B
AIDS diagnostics by use of recombinant antigens
A new desizing enzyme shows the changing nature of enzyme production
J Biotech 1995; 38 : 195-7

5. KIONKA C and PETRI T
Erythropoietin - Improving the quality of life of dialysis patients
Interferon beta-1b for the treatment of multiple sclerosis
J Biotech 1995; 43 : 73-76

6. FALKNER E and MAURER-FOGY I, TERRÉ J, CHAPPUIS G, LOMBARD M and DESMETTRE P
Recombinant interferon gamma for the therapy of immunological Eradication of rabies, using a rec-DNA vaccine
J Biotech 1996; 46 : 155-9

7. WERZ W and WERNER R and TILL R
Tissue plasminogen activator and Granulocyte-macrophage colony-stimulating factor
J Biotech 1998; 61 : 157-161

8. HEDNER U, LUND-HANSEN T, HEIKOOP J.C. and OLIJVE W.
Coagulation factor VII and Folicle stimulating hormone
J Biotech 1998; 61 : 231-236

9. VANMACHELEN E, VANDERSTICHELE H, JONES B and QUAX W
Alzheimer tau test and Detergent cellulase
J Biotech 1998; 66 : 229-233

10. VAN DIJCK P.W.M.
Chymosin and Phytase
J Biotech 1999; 67 : 77-80

11. HOPPE H, CROOY P and LOBET Y
Glucocerebrosidase and Lyme disease vaccine
J Biotech 2000; 76 : 259-263

12. OLSEN T and DIDERICHSEN B, FONJALLAZ P and LOUMAYE E
Glucagon and Recombinant LH
J Biotech 2000; 79 : 185-189

   BACK